Publications

Abruzzo, T; Abraham, K; Karani, KB; Geller, JI; Vadivelu, S; Racadio, JM; Zhang, B; Correa, ZM. Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma. American Journal of Neuroradiology. 2021; 42:354-361.

Ambady, P; Bagley, SJ; Blakeley, J; Brooks, T; Bussière, MR; Campian, JL; Chan, MD; Chukwueke, UN; Cramer, CK; Couture, DE; et al. Contributors List. Neuro-Oncology for the Clinical Neurologist. 2021.

Bartlett, AL; Romick-Rosendale, L; Nelson, A; Abdullah, S; Luebbering, N; Bartlett, J; Brusadelli, M; Palumbo, JS; Lake, K; Litts, B; et al. Tryptophan metabolism is dysregulated in individuals with Fanconi anemia. Blood Advances. 2021; 5:250-261.

Bedard, MC; Brusadelli, MG; Carlile, A; Ruiz-Torres, S; Lodin, H; Lee, D; Kofron, M; Lambert, PF; Lane, A; Ameziane, N; et al. Patient-Derived Organotypic Epithelial Rafts Model Phenotypes in Juvenile-Onset Recurrent Respiratory Papillomatosis. Viruses. 2021; 13.

Blakeley, J; Langmead, S; de Blank, P. Chapter 16 Approach to patients with the neoplasms associated with neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Neuro-Oncology for the Clinical Neurologist. 2021.

Cunningham, S; McCauley, S; Vairamani, K; Speth, J; Girdhani, S; Abel, E; Sharma, RA; Perentesis, JP; Wells, SI; Mascia, A; et al. FLASH Proton Pencil Beam Scanning Irradiation Minimizes Radiation-Induced Leg Contracture and Skin Toxicity in Mice. Cancers. 2021; 13.

D’Souza, AM; Cast, A; Kumbaji, M; Rivas, M; Gulati, R; Johnston, M; Smithrud, D; Geller, J; Timchenko, N. Small Molecule Cjoc42 Improves Chemo-Sensitivity and Increases Levels of Tumor Suppressor Proteins in Hepatoblastoma Cells and in Mice by Inhibiting Oncogene Gankyrin. Frontiers in Pharmacology. 2021; 12.

DeWire, M; Erker, C; Hummel, TR; Chow, LM L; de Blank, P; Salloum, R; Pillay-Smiley, N; Hoffman, L; Gilger, E; Gallagher, M; et al. Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers. Journal of Neuro-Oncology. 2021; 152:107-114.

Emberesh, M; Rubinstein, JD; Young, J; Benoit, SW; Dandoy, CE; Weiss, BD. Tolerance of dinutuximab therapy for treatment of high-risk neuroblastoma in two patients with end-stage renal disease on dialysis. Pediatric Blood and Cancer. 2021; 68.

Fabrizio, VA; Phillips, CL; Baggott, C; Prabhu, S; Pacenta, HL; Rossoff, J; Stefanski, HE; Talano, J; Moskop, A; Margossian, S; et al. 224 Real-World Treatment of Pediatric Patients with Relapsed/Refractory CNS B-Cell Acute Lymphoblastic Leukemia Using Tisagenlecleucel. 2021; 27:s202-s203.

Graham, RT; Coven, SL; Stanek, JR; Folta, A; Hollingsworth, EW; Finlay, JL; Kumar, R. Venous thromboembolism in children with central nervous system tumors: Comparison of an institutional cohort to a national administrative database. Pediatric Blood and Cancer. 2021; 68.

Granger, M; Naranjo, A; Bagatell, R; DuBois, SG; McCune, JS; Tenney, SC; Weiss, BD; Mosse, YP; Asgharzadeh, S; Grupp, SA; et al. Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1. 2021.

Ibrahimova, A; Pommert, L; Breese, EH. Acute Leukemia in Infants. Current Oncology Reports. 2021; 23.

Milewski, D; Shukla, S; Gryder, BE; Pradhan, A; Donovan, J; Sudha, P; Vallabh, S; Pyros, A; Xu, Y; Barski, A; et al. FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma. Oncogene. 2021; 40:2182-2199.

Moskop, A; Breese, E; Guest, E; Pommert, L; Baggott, C; Prabhu, S; Pacenta, HL; Phillips, CL; Rossoff, J; Stefanski, HE; et al. 76 Real-World Use of Tisagenlecleucel in Infant Acute Lymphoblastic Leukemia. 2021; 27:s73-s74.

Moskop, A; Pommert, L; Thakrar, P; Talano, J; Phelan, R. Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia. Pediatric Blood and Cancer. 2021; 68.

Moskop, A; Talano, J; Verneris, MR; Baggott, C; Prabhu, S; Pacenta, HL; Phillips, CL; Rossoff, J; Stefanski, HE; Margossian, S; et al. 405 Immune Reconstitution and Infections in the Real-World Use of Tisagenlecleucel in Pediatric and Young Adult ALL. 2021; 27:s335-s336.

Muraleedharan, R; Nardini, D; Waclaw, RR; Dasgupta, B. Analysis of reactive astrogliosis in mouse brain using in situ hybridization combined with immunohistochemistry. 2021; 2.

Oatman, N; Dasgupta, N; Arora, P; Choi, K; Gawali, MV; Gupta, N; Parameswaran, S; Salomone, J; Reisz, JA; Lawler, S; et al. Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancer. Science advances. 2021; 7.

Pommert, L; Burns, R; Furumo, Q; Pulakanti, K; Brandt, J; Burke, MJ; Rao, S. Novel germline TRAF3IP3 mutation in a dyad with familial acute B lymphoblastic leukemia. 2021.

Pommert, L; Liberio, N; Ng, JS; Egelund, TA; Siver, MJ; Katzenstein, HM; Burke, MJ. Concurrent Imatinib Dosing With High-dose Methotrexate Leads to Acute Kidney Injury and Delayed Methotrexate Clearance in Pediatric Patients With Philadelphia Chromosome-positive B-Cell Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 2021; 43:e296-e300.

Sauter, SL; Zhang, X; Romick-Rosendale, L; Wells, SI; Myers, KC; Brusadelli, MG; Poff, CB; Brown, DR; Panicker, G; Unger, ER; et al. Human Papillomavirus Oral- and Sero- Positivity in Fanconi Anemia. Cancers. 2021; 13.

Schultz, L; Baggott, C; Prabhu, S; Pacenta, HL; Phillips, CL; Rossoff, J; Talano, J; Moskop, A; Margossian, S; Verneris, MR; et al. 241 Predictive Value of Next-Generation Sequencing (NGS) Following Tisagenlecleucel in Pediatric and Young Adult B-Cell Acute Lymphoblastic Leukemia. 2021; 27:s216-s217.

Sertorio, M; Nowrouzi, A; Akbarpour, M; Chetal, K; Salomonis, N; Brons, S; Mascia, A; Ionascu, D; McCauley, S; Kupneski, T; et al. Differential transcriptome response to proton versus X-ray radiation reveals novel candidate targets for combinatorial PT therapy in lymphoma. Radiotherapy and Oncology. 2021; 155:293-303.

Stefanski, HE; Verneris, MR; Eaton, A; Baggott, C; Prabhu, S; Pacenta, HL; Phillips, CL; Rossoff, J; Talano, J; Moskop, A; et al. 126 Post-Relapse Outcomes Following Tisagenlecleucel: Poor Survival, Despite Current Salvage Therapies: Results from the Pediatric Real World CAR Consortium (PRWCC). 2021; 27:s117-s118.

Sung, AJ; Weiss, BD; Sharp, SE; Zhang, B; Trout, AT. Prognostic significance of pretreatment 18F-FDG positron emission tomography/computed tomography in pediatric neuroblastoma. Pediatric Radiology. 2021.

Wang, Y; Pandey, RN; Roychoudhury, K; Milewski, D; Kalin, TV; Szabo, S; Pressey, JG; Hegde, RS. TARGETING EYA3 IN EWING SARCOMA RETARDS TUMOR GROWTH AND ANGIOGENESIS. Molecular Cancer Therapeutics. 2021.

Weiss, BD; Wolters, PL; Plotkin, SR; Widemann, BC; Tonsgard, JH; Blakeley, J; Allen, JC; Schorry, E; Korf, B; Robison, NJ; et al. NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas. Journal of Clinical Oncology. 2021; 39:797-806.

Woodruff, TK; Ataman-Millhouse, L; Acharya, KS; Almeida-Santos, T; Anazodo, A; Anderson, RA; Appiah, L; Bader, J; Becktell, K; Brannigan, RE; et al. A View from the past into our collective future: the oncofertility consortium vision statement. Journal of Assisted Reproduction and Genetics. 2021; 38:3-15.

Wright, KD; Yao, X; London, WB; Kao, PC; Gore, L; Hunger, S; Geyer, R; Cohen, KJ; Allen, JC; Katzenstein, HM; et al. A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. Pediatric Blood and Cancer. 2021; 68.